Siloam Vision
Siloam Vision is a medical technology company focused on reducing preventable blindness and improving health worldwide through advanced retinal imaging devices and artificial intelligence-enabled eye care solutions. The company develops and provides systems for ultra-widefield retinal imaging and AI-assisted diagnosis, targeting populations with limited access to traditional eye care. Established by domain experts, the company partners with major academic and global health organizations to increase accessibility and standardization of vision care for individuals of all ages, especially preterm infants vulnerable to retinopathy of prematurity.
Industries
N/A
Products
Software platform enabling guided patient scheduling, automated reminders, secure data management, and remote image review for retinopathy of prematurity management.
Clinical decision support platform integrating advanced AI algorithms for point-of-care detection, grading, and diagnosis of retinopathy of prematurity.
Handheld scanning laser ophthalmoscope designed for high-resolution ultra-widefield imaging of the retina across all patient ages, supporting both contact and non-contact imaging modes.
Handheld OCT device for ultra-widefield, high-resolution, cross-sectional imaging and angiography of the retina in patients from neonates to adults.
Software platform enabling guided patient scheduling, automated reminders, secure data management, and remote image review for retinopathy of prematurity management.
Clinical decision support platform integrating advanced AI algorithms for point-of-care detection, grading, and diagnosis of retinopathy of prematurity.
Handheld scanning laser ophthalmoscope designed for high-resolution ultra-widefield imaging of the retina across all patient ages, supporting both contact and non-contact imaging modes.
Handheld OCT device for ultra-widefield, high-resolution, cross-sectional imaging and angiography of the retina in patients from neonates to adults.
Expertise Areas
- Retinal imaging
- Artificial intelligence in ophthalmology
- Telemedicine screening
- Clinical workflow automation
Key Technologies
- Scanning laser ophthalmoscopy (SLO)
- Optical coherence tomography (OCT)
- Ultra-widefield retinal imaging
- AI-based image analysis
Key People
Chief Executive Officer, Co-Founder
Co-Founder
Chief Development Officer, Co-Founder
Chief Information Officer, Co-Founder
Chief Technology Officer
Chief Operating Officer
Chief Executive Officer, Co-Founder
Co-Founder
Chief Development Officer, Co-Founder
Chief Information Officer, Co-Founder
Chief Technology Officer
Chief Operating Officer
News & Updates
Received FDA Breakthrough Device Designation for an optical coherence tomography technology aimed at preventing infant blindness.
Awarded a Phase II Small Business Innovation Research (SBIR) contract to advance AI-enabled retinal imaging technology.
Received a research grant from the US National Institutes of Health for developing ultrawide-field portable pediatric retinal imaging systems.
Press release describing clinical study results demonstrating statistically significant improvements in diagnostic accuracy and inter-reader agreement for plus disease in ROP diagnosis using an AI-powered platform.
Announcement of SBIR Phase II contract aimed at developing AI-enabled retinal imaging technology with applications in military and readiness contexts.
Third-party article acknowledging the company receiving FDA Breakthrough Device Designation for their OCT technology targeting prevention of infant blindness.
Received FDA Breakthrough Device Designation for an optical coherence tomography technology aimed at preventing infant blindness.
Awarded a Phase II Small Business Innovation Research (SBIR) contract to advance AI-enabled retinal imaging technology.
Received a research grant from the US National Institutes of Health for developing ultrawide-field portable pediatric retinal imaging systems.
Press release describing clinical study results demonstrating statistically significant improvements in diagnostic accuracy and inter-reader agreement for plus disease in ROP diagnosis using an AI-powered platform.
Announcement of SBIR Phase II contract aimed at developing AI-enabled retinal imaging technology with applications in military and readiness contexts.
Third-party article acknowledging the company receiving FDA Breakthrough Device Designation for their OCT technology targeting prevention of infant blindness.